BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28340014)

  • 1. Association between right ventricular lead position and clinical outcomes in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Riahi S; Petersen HH; Haarbo J; Jørgensen OD; Nielsen JC
    Europace; 2018 Apr; 20(4):629-635. PubMed ID: 28340014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
    Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anterior left ventricular lead position is associated with increased mortality and non-response in cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Riahi S; Petersen HH; Haarbo J; Jørgensen OD; Nielsen JC
    Int J Cardiol; 2016 Nov; 222():157-162. PubMed ID: 27494729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular lead location and outcomes among patients with cardiac resynchronization therapy: A meta-analysis.
    Ali-Ahmed F; Dalgaard F; Allen Lapointe NM; Kosinski AS; Blumer V; Morin DP; Sanders GD; Al-Khatib SM
    Prog Cardiovasc Dis; 2021; 66():53-60. PubMed ID: 33864874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.
    Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V
    Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients.
    Daimee UA; Klein HU; Giudici MC; Zareba W; McNitt S; Polonsky B; Moss AJ; Kutyifa V
    J Interv Card Electrophysiol; 2018 Jul; 52(2):185-194. PubMed ID: 29572715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICD lead type and RV lead position in CRT-D recipients.
    Benz AP; Vamos M; Erath JW; Bogyi P; Duray GZ; Hohnloser SH
    Clin Res Cardiol; 2018 Dec; 107(12):1122-1130. PubMed ID: 29797055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function.
    Kiehl EL; Makki T; Kumar R; Gumber D; Kwon DH; Rickard JW; Kanj M; Wazni OM; Saliba WI; Varma N; Wilkoff BL; Cantillon DJ
    Heart Rhythm; 2016 Dec; 13(12):2272-2278. PubMed ID: 27855853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.
    Alpendurada F; Guha K; Sharma R; Ismail TF; Clifford A; Banya W; Mohiaddin RH; Pennell DJ; Cowie MR; McDonagh T; Prasad SK
    J Cardiovasc Magn Reson; 2011 Oct; 13(1):68. PubMed ID: 22040270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry.
    Leshem E; Suleiman M; Laish-Farkash A; Haim M; Geist M; Luria D; Glikson M; Goldenberg I; Michowitz Y;
    J Interv Card Electrophysiol; 2018 Jan; 51(1):5-12. PubMed ID: 29274032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.